Detalles de la búsqueda
1.
Risk factors for human papillomavirus infection and disease: A targeted literature summary.
J Med Virol;
96(2): e29420, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377121
2.
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Lancet;
399(10337): 1790-1798, 2022 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483400
3.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Int J Gynecol Cancer;
33(4): 446-461, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958755
4.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.
J Low Genit Tract Dis;
27(2): 131-145, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951985
5.
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Gynecol Oncol;
165(1): 23-29, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177279
6.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions.
Int J Gynecol Cancer;
32(7): 830-845, 2022 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35728950
7.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.
J Low Genit Tract Dis;
26(3): 229-244, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763611
8.
The impact of p16ink4a positivity in invasive vulvar cancer on disease-free and disease-specific survival, a retrospective study.
Arch Gynecol Obstet;
301(3): 753-759, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970493
9.
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
Gynecol Oncol;
154(1): 110-117, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982556
10.
Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery.
Arch Gynecol Obstet;
300(4): 1015-1022, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468203
11.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Lancet;
390(10108): 2143-2159, 2017 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28886907
12.
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
N Engl J Med;
372(8): 711-23, 2015 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25693011
13.
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Int J Gynecol Cancer;
33(4): 462-464, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889817
14.
Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation.
Int J Gynecol Cancer;
2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114163
15.
The impact of written information and counseling (WOMAN-PRO II Program) on symptom outcomes in women with vulvar neoplasia: A multicenter randomized controlled phase II study.
Gynecol Oncol;
146(1): 114-122, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28483270
16.
Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee.
Int J Gynecol Cancer;
2022 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820716
17.
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.
Int J Cancer;
137(12): 2858-68, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26096203
18.
European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.
Int J Gynecol Cancer;
30(8): 1097-1100, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487685
19.
What do women with gynecologic cancer know about HPV and their individual disease? A pilot study.
BMC Cancer;
14: 388, 2014 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885465
20.
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
Int J Cancer;
132(4): 854-67, 2013 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22752992